Featured Research

from universities, journals, and other organizations

University Of Kentucky Researcher Develops Nicotinic Drugs With R.J. Reynolds

Date:
July 28, 1999
Source:
University Of Kentucky Medical Center
Summary:
Nicotine researcher Peter Crooks, Ph.D., professor of pharmaceutical sciences at the University of Kentucky College of Pharmacy, and tobacco giant R.J. Reynolds may seem like an unlikely pair, but together they're hoping to develop new drugs which provide benefits from relieving pain to improving memory.

LEXINGTON, KY - Nicotine researcher Peter Crooks, Ph.D., professor of pharmaceutical sciences at the University of Kentucky College of Pharmacy, and tobacco giant R.J. Reynolds may seem like an unlikely pair, but together they're hoping to develop new drugs which provide benefits from relieving pain to improving memory.

Related Articles


Although most people are aware of the negative effects of nicotine, Crooks has been in the forefront of research into its beneficial effects for nearly 20 years and began a partnership in 1992 with R.J. Reynolds in a drug discovery program.

The partnership with the therapeutics discovery group, now called Targacept, has resulted in several potential drug candidates being evaluated for clinical trials.

Nicotine is the addictive ingredient in tobacco products that keeps many users hooked, but during the past several years, researchers like Crooks have worked to develop nicotine analogs, and to focus on the beneficial impact they have on Alzheimer's disease, Parkinson's disease, chronic pain, obesity, and depression.

Crooks has been studying the medicinal chemistry of nicotine and nicotine analogs since the early 1980s. During this time, he and his coworkers have completed extensive studies on the metabolism and pharmacokinetics of nicotine in and around the brain.

Collaborating with colleague Linda Dwoskin, Ph.D., UK professor of pharmaceutical sciences, Crooks has investigated the pharmacological actions of several nicotine metabolites and nicotine analogs on the brain have been investigated.

Nine patents on the nicotine analog work have been licensed for development by Targacept, and several others recently have been filed with the U.S. Patent office. However, Dr. Crooks said it is too early to determine if any of these novel molecules ever will find their way to the pharmacy shelves. "Clinical trials take several years and often include several phases with only about one in 10,000 drugs ever making it to the market."


Story Source:

The above story is based on materials provided by University Of Kentucky Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Kentucky Medical Center. "University Of Kentucky Researcher Develops Nicotinic Drugs With R.J. Reynolds." ScienceDaily. ScienceDaily, 28 July 1999. <www.sciencedaily.com/releases/1999/07/990728073542.htm>.
University Of Kentucky Medical Center. (1999, July 28). University Of Kentucky Researcher Develops Nicotinic Drugs With R.J. Reynolds. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/1999/07/990728073542.htm
University Of Kentucky Medical Center. "University Of Kentucky Researcher Develops Nicotinic Drugs With R.J. Reynolds." ScienceDaily. www.sciencedaily.com/releases/1999/07/990728073542.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Mind & Brain News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Former NFL Players Donate Brains to Science

Former NFL Players Donate Brains to Science

Reuters - US Online Video (Mar. 3, 2015) Super Bowl champions Sidney Rice and Steve Weatherford donate their brains, post-mortem, to scientific research into repetitive brain trauma. Jillian Kitchener reports. Video provided by Reuters
Powered by NewsLook.com
Alzheimer's Protein Plaque Found In 20-Year-Olds

Alzheimer's Protein Plaque Found In 20-Year-Olds

Newsy (Mar. 3, 2015) Researchers found an abnormal protein associated with Alzheimer&apos;s disease in the brains of 20-year-olds. Video provided by Newsy
Powered by NewsLook.com
This Nasal Treatment Could Help Ease Migraine Pain

This Nasal Treatment Could Help Ease Migraine Pain

Newsy (Mar. 2, 2015) Researchers gave lidocaine to 112 patients, and about 88 percent of the subjects said they needed less migraine-relief medicine the next day. Video provided by Newsy
Powered by NewsLook.com
How Facebook Use Can Lead To Depression

How Facebook Use Can Lead To Depression

Newsy (Mar. 1, 2015) Margaret Duffy of the University of Missouri talks about her study on the social network and the envy and depression that Facebook use can cause. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins